mechanism of action for glp-1 receptor agonists Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Agonists: A Scoping Review Trends in the Development of

This study investigates the effects of allulose, a rare sugar shown to reduce blood glucose, in a rat model of diet-induced obesity and T2D

A recent study, published in the Journal of Pharmacy and Pharmacology Research, sugges

When oxidative demand approaches the regenerative capacity of nicotinamide adenine dinucleotide (NAD)/ nicotinamide adenine dinucleotide phosphate (NADPH

Tirzepatide, a novel twincretin drug, significantly improves weight loss and glycemic control in obese and type 2 diabetes patients, outperforming traditional treatments in clinical trials.

DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006

Lets explore each type of medication in more detail.